These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11390631)

  • 21. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.
    Staudt MR; Dittmer DP
    Virology; 2006 Jun; 350(1):192-205. PubMed ID: 16616289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
    AuCoin DP; Colletti KS; Cei SA; Papousková I; Tarrant M; Pari GS
    Virology; 2004 Jan; 318(2):542-55. PubMed ID: 14972523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation of the open reading frame 35 encoded by Kaposi's sarcoma-associated herpesvirus.
    Masa SR; Lando R; Sarid R
    Virology; 2008 Feb; 371(1):14-31. PubMed ID: 17963810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses.
    Damania B; Jeong JH; Bowser BS; DeWire SM; Staudt MR; Dittmer DP
    J Virol; 2004 May; 78(10):5491-9. PubMed ID: 15113928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional co-operation between the Kaposi's sarcoma-associated herpesvirus ORF57 and ORF50 regulatory proteins.
    Malik P; Blackbourn DJ; Cheng MF; Hayward GS; Clements JB
    J Gen Virol; 2004 Aug; 85(Pt 8):2155-2166. PubMed ID: 15269354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.
    Chang PJ; Miller G
    J Virol; 2004 Oct; 78(19):10657-73. PubMed ID: 15367633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis.
    Chudasama P; Konrad A; Jochmann R; Lausen B; Holz P; Naschberger E; Neipel F; Britzen-Laurent N; Stürzl M
    Oncogene; 2015 Jan; 34(5):639-49. PubMed ID: 24469037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11.
    Chen L; Park MS
    Virus Res; 2009 Jun; 142(1-2):160-8. PubMed ID: 19428749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein Represses Cellular MDM2 Expression via Suppressing the Sp1- and p53-Mediated Transactivation.
    Lin CI; Wang SS; Hung CH; Chang PJ; Chen LW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.
    Liang Y; Chang J; Lynch SJ; Lukac DM; Ganem D
    Genes Dev; 2002 Aug; 16(15):1977-89. PubMed ID: 12154127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
    Seo T; Park J; Choe J
    Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lytic switch protein (ORF50) response element in the Kaposi's sarcoma-associated herpesvirus K8 promoter is located within but does not require a palindromic structure.
    Seaman WT; Quinlivan EB
    Virology; 2003 May; 310(1):72-84. PubMed ID: 12788632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's sarcoma-associated herpesvirus immediate early gene activity.
    Lacoste V; de la Fuente C; Kashanchi F; Pumfery A
    Front Biosci; 2004 Sep; 9():2245-72. PubMed ID: 15353285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Lim C; Gwack Y; Hwang S; Kim S; Choe J
    J Biol Chem; 2001 Aug; 276(33):31016-22. PubMed ID: 11425857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of p53 tumor suppressor by viral interferon regulatory factor.
    Nakamura H; Li M; Zarycki J; Jung JU
    J Virol; 2001 Aug; 75(16):7572-82. PubMed ID: 11462029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Pan HY; Zhang YJ; Wang XP; Deng JH; Zhou FC; Gao SJ
    J Virol; 2003 Sep; 77(18):9758-68. PubMed ID: 12941884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance.
    Chang PJ; Shedd D; Miller G
    J Virol; 2008 Oct; 82(19):9700-16. PubMed ID: 18653447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
    Li M; Lee H; Guo J; Neipel F; Fleckenstein B; Ozato K; Jung JU
    J Virol; 1998 Jul; 72(7):5433-40. PubMed ID: 9620998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi sarcoma herpesvirus-encoded interferon regulator factors.
    Offermann MK
    Curr Top Microbiol Immunol; 2007; 312():185-209. PubMed ID: 17089798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.